RARPKB

Groups information

Group name

Whole-gland treatment (Total)

Groups definition

patients underwent sRARP after focal or whole-gland primary treatment

Baseline information

Age

67

Age remark

Median (IQR) (yrs)

BMI

29

PSA

6.4

American Society of Aneshesiologists (ASA) physical status classification

average ASA

2

Charlson comorbidity index (CCI)

Risk classification

low

2(4)

intermediate

20 (44)

high

23 (51)

Risk remark

D'Amico risk class